chr,start,end,id,genes,diseases,variant_type,variant_name,variant_mode,pmid,gene_score,disease_score
,,,"tmVar:p|Allele|Q,E|;VariantGroup:0;CorrespondingGene:6615;CorrespondingSpecies:9606",SNAI1 (6615); DDR2 (4921); FOXQ1 (94234),cancer (MESH:D009369); TNBC (MESH:D064726); triple-negative breast cancer (MESH:D064726),unknown,glutamine-glutamate,unknown,36713812,8; 9; 8,0; 7; 7
,,,tmVar:p|SUB|D|816|V;HGVS:p.D816V;VariantGroup:0;CorrespondingGene:3815;RS#:121913507;CorrespondingSpecies:9606;CA#:123513,KIT (3815); kit (3815); ERG (2078); TWIST1 (7291); BAIAP2 (10458); GRM2 (2912); KRTCAP3 (200634); FOXQ1 (94234),systemic mastocytosis (MESH:D034721); mastocytosis (D008415); mastocytosis (MESH:D008415); mast cell disease (MESH:D000090362); ISM (D034721); anaphylaxis (MESH:D000707); anaphylaxis (D000707); allergy (MESH:D004342); Mastocytosis (D008415); Mastocytosis (MESH:D008415); systemic mastocytosis (D034721); allergy (D004342); ISM (MESH:D034721),substitution,p.D816V,unknown,37762215,10; 10; 9; 9; 6; 8; 8; 9,0; 10; 0; 0; 8; 0; 6; 0; 10; 0; 8; 5; 0
,,,tmVar:rs1345417;VariantGroup:2;RS#:1345417,EDAR (10913); SOX2 (6657); FOXD1 (2297),,unknown,rs1345417,unknown,30248107,0; 9; 9,
,,,tmVar:rs12651896;VariantGroup:0;RS#:12651896,EDAR (10913); SOX2 (6657); FOXD1 (2297),,unknown,rs12651896,unknown,30248107,8; 9; 9,
,,,tmVar:rs1866188;VariantGroup:1;CorrespondingGene:3987;RS#:1866188;CorrespondingSpecies:9606,EDAR (10913); SOX2 (6657); FOXD1 (2297),,unknown,rs1866188,unknown,30248107,9; 8; 8,
,,,tmVar:p|SUB|H|267|Y;HGVS:p.H267Y;VariantGroup:3;CorrespondingGene:5228;CorrespondingSpecies:9606,PlGF (5228); FOXD1 (2297),RPL (MESH:D000026); RIF (MESH:D051437); female-related diseases (MESH:D005831); infertility (MESH:D007246); intra-uterine growth restriction (MESH:D005317); preeclampsia (MESH:D011225); implantation (MESH:D057873); IUGR (MESH:D005317); PE (MESH:D011225); recurrent pregnancy loss (MESH:D000026); reproductive disorders (MESH:D060737); implantation failure (MESH:D051437); placental diseases (MESH:D010922),substitution,p.H267Y,unknown,31395028,6; 8,9; 0; 0; 0; 4; 4; 7; 4; 4; 9; 0; 0; 0
,,,tmVar:p|DEL|57|R;HGVS:p.R57del;VariantGroup:0;CorrespondingGene:2297;RS#:750578392;CorrespondingSpecies:9606;CA#:3303117,PlGF (5228); FOXD1 (2297),RPL (MESH:D000026); RIF (MESH:D051437); female-related diseases (MESH:D005831); infertility (MESH:D007246); intra-uterine growth restriction (MESH:D005317); preeclampsia (MESH:D011225); implantation (MESH:D057873); IUGR (MESH:D005317); PE (MESH:D011225); recurrent pregnancy loss (MESH:D000026); reproductive disorders (MESH:D060737); implantation failure (MESH:D051437); placental diseases (MESH:D010922),deletion,p.R57del,unknown,31395028,0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|A|356|G;HGVS:p.A356G;VariantGroup:2;CorrespondingGene:2297;RS#:917127030;CorrespondingSpecies:9606;CA#:121212330,PlGF (5228); FOXD1 (2297),RPL (MESH:D000026); RIF (MESH:D051437); female-related diseases (MESH:D005831); infertility (MESH:D007246); intra-uterine growth restriction (MESH:D005317); preeclampsia (MESH:D011225); implantation (MESH:D057873); IUGR (MESH:D005317); PE (MESH:D011225); recurrent pregnancy loss (MESH:D000026); reproductive disorders (MESH:D060737); implantation failure (MESH:D051437); placental diseases (MESH:D010922),substitution,p.A356G,unknown,31395028,0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|I|364|M;HGVS:p.I364M;VariantGroup:1;CorrespondingGene:2297;RS#:992724147;CorrespondingSpecies:9606;CA#:121212329,PlGF (5228); FOXD1 (2297),RPL (MESH:D000026); RIF (MESH:D051437); female-related diseases (MESH:D005831); infertility (MESH:D007246); intra-uterine growth restriction (MESH:D005317); preeclampsia (MESH:D011225); implantation (MESH:D057873); IUGR (MESH:D005317); PE (MESH:D011225); recurrent pregnancy loss (MESH:D000026); reproductive disorders (MESH:D060737); implantation failure (MESH:D051437); placental diseases (MESH:D010922),substitution,p.I364M,unknown,31395028,7; 8,0; 0; 0; 4; 5; 5; 6; 0; 0; 9; 0; 0; 0
,,,tmVar:p|SUB|V|600|E;HGVS:p.V600E;VariantGroup:0;CorrespondingGene:673;RS#:113488022;CorrespondingSpecies:9606;CA#:123643,CTGF (1490); FOXD1 (2297); BRAF (673); connective tissue growth factor (1490); MEK (5609); forkhead box D1 (2297),metastatic melanoma (MESH:D008545); skin cancer (MESH:D012878); Metastatic melanoma (MESH:D008545); melanoma (MESH:D008545),substitution,p.V600E,unknown,33837564,0; 0; 0; 0; 0; 0,0; 0; 0; 0
,,,tmVar:p|SUB|K|3|M;HGVS:p.K3M;VariantGroup:0;CorrespondingGene:2297;CorrespondingSpecies:9606,FOXD1 (2297),tumorigenesis (MESH:D063646); melanoma (MESH:D008545),substitution,p.K3M,unknown,35223844,8,7; 8
,,,tmVar:p|SUB|M|190|I;HGVS:p.M190I;VariantGroup:0;CorrespondingGene:3174;RS#:1805098;CorrespondingSpecies:9606;CA#:4786371,HNF-4gamma (3174); HNF-4alpha (3172); hepatocyte nuclear factor (HNF)-4gamma (3174),autosomal-dominant type 2 diabetes (MESH:D003924); maturity-onset diabetes (MESH:D003924); diabetes (MESH:D003920); type 2 diabetes (MESH:D003924),substitution,p.M190I,unknown,10512380,6; 0; 6,9; 0; 5; 8
,,,tmVar:p|SUB|G|12|D;HGVS:p.G12D;VariantGroup:0;CorrespondingGene:3845;RS#:121913529;CorrespondingSpecies:9606;CA#:122538,EGFR (1956); AP-1 (2354); Kras (3845); NKX2-1 (7270); NKX2-1 (21869); NK2 homeobox 1 (7080); TTF-1 (7270); NKX2-1 (7080); AP-1 (16476); Nkx2-1 (21869),mucinous tumors (MESH:D018297); lung disease (MESH:D008171); mucinous pulmonary adenocarcinoma (MESH:D002288); lung tumorigenesis (MESH:D063646); pulmonary tumors (MESH:D009369); tumorigenesis (MESH:D063646); tumor (MESH:D009369); Mucinous adenocarcinoma of the lung (MESH:D000077192); mucinous adenocarcinomas (MESH:D002288); mucinous adenocarcinoma of the lung (MESH:D000077192),substitution,p.G12D,unknown,23143308,4; 4; 9; 4; 0; 4; 0; 8; 6; 7,8; 0; 0; 0; 7; 9; 6; 8; 8; 9
,,,tmVar:p|SUB|L|858|R;HGVS:p.L858R;VariantGroup:1;CorrespondingGene:1956;RS#:121434568;CorrespondingSpecies:9606;CA#:126713,EGFR (1956); AP-1 (2354); Kras (3845); NKX2-1 (21869); NK2 homeobox 1 (7080); TTF-1 (7270); NKX2-1 (7080); AP-1 (16476); Nkx2-1 (21869),mucinous tumors (MESH:D018297); lung disease (MESH:D008171); mucinous pulmonary adenocarcinoma (MESH:D002288); lung tumorigenesis (MESH:D063646); pulmonary tumors (MESH:D009369); tumorigenesis (MESH:D063646); mucinous adenocarcinomas (MESH:D002288); Mucinous adenocarcinoma of the lung (MESH:D000077192); tumor (MESH:D009369),substitution,p.L858R,unknown,23143308,5; 4; 8; 9; 7; 5; 9; 4; 7,8; 0; 0; 0; 5; 7; 8; 8; 5
,,,tmVar:rs1836882;VariantGroup:0;CorrespondingGene:50507;RS#:1836882;CorrespondingSpecies:9606,HNF3gamma (3171); nicotinamide adenine dinucleotide phosphate oxidase 4 (50507); NOX4 (50507),metabolic disorders (MESH:D008659),unknown,rs1836882,unknown,24392026,8; 9; 9,6
,,,tmVar:rs28666870;VariantGroup:1;CorrespondingGene:3171;RS#:28666870;CorrespondingSpecies:9606,FOXA3 (3171); Foxa3 (3171),,unknown,rs28666870,unknown,25672906,8; 8,
,,,tmVar:c|SUB|C|185|T;HGVS:c.185C>T;VariantGroup:2;CorrespondingGene:3171;RS#:758644255;CorrespondingSpecies:9606;CA#:9524458,FOXA3 (3171); Foxa3 (3171),,substitution,c.185C>T,unknown,25672906,8; 4,
,,,tmVar:p|SUB|S|62|L;HGVS:p.S62L;VariantGroup:2;CorrespondingGene:3171;RS#:758644255;CorrespondingSpecies:9606;CA#:9524458,FOXA3 (3171); Foxa3 (3171),,substitution,p.S62L,unknown,25672906,9; 7,
,,,tmVar:c|SUB|C|731|T;HGVS:c.731C>T;VariantGroup:0;CorrespondingGene:3171;RS#:760604416;CorrespondingSpecies:9606;CA#:9524577,FOXA3 (3171); Foxa3 (3171),,substitution,c.731C>T,unknown,25672906,8; 8,
,,,tmVar:p|SUB|A|244|V;HGVS:p.A244V;VariantGroup:0;CorrespondingGene:3171;RS#:760604416;CorrespondingSpecies:9606;CA#:9524577,FOXA3 (3171); Foxa3 (3171),,substitution,p.A244V,unknown,25672906,9; 0,
,,,tmVar:p|SUB|G|135|E;HGVS:p.G135E;VariantGroup:0;CorrespondingGene:79831;RS#:576036750;CorrespondingSpecies:9606;CA#:7973407,HBx (944566); FOXA3 (3171); HNF4A (3172); CEBPA (1050); JMJD5 (79831); jumonji C-domain-containing 5 (79831),HCC (MESH:D006528); hepatocellular carcinoma (MESH:D006528); liver diseases (MESH:D008107); cirrhosis (MESH:D005355); hepatitis (MESH:D056486),substitution,p.G135E,unknown,26792738,0; 0; 0; 0; 0; 0,0; 0; 0; 0; 0
,,,tmVar:p|SUB|G|135|E;HGVS:p.G135E;VariantGroup:0;CorrespondingGene:79831;RS#:576036750;CorrespondingSpecies:9606;CA#:7973407,HBx (944566); FOXA3 (3171); HNF4A (3172); CEBPA (1050); JMJD5 (79831); jumonji C-domain-containing 5 (79831),HCC (MESH:D006528); hepatocellular carcinoma (MESH:D006528); liver diseases (MESH:D008107); cirrhosis (MESH:D005355); hepatitis (MESH:D056486),substitution,p.G135E,unknown,26792738,0; 0; 0; 0; 0; 0,0; 0; 0; 0; 0
,,,tmVar:rs17111633;VariantGroup:0;CorrespondingGene:26507;RS#:17111633;CorrespondingSpecies:9606,FOXA3 (3171); PPARG (5468); THRB (7068); PRKCA (5578); MYPOP (339344); CNNM1 (26507),placental abruption (MESH:D000037),unknown,rs17111633,unknown,27806667,10; 0; 0; 0; 4; 10,0
,,,tmVar:rs35767;VariantGroup:0;CorrespondingGene:3479;RS#:35767;CorrespondingSpecies:9606,IGF1 (3479); C/EBPD (1052); FOXA3 (3171); C (1052); CCAAT/enhancer-binding-protein delta (1052),,unknown,rs35767,unknown,27910883,9; 8; 6; 7; 8,
,,,tmVar:c|SUB|T|521|C;HGVS:c.521T>C;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606;CA#:6476722,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,substitution,c.521T>C,unknown,30100615,6; 6; 6; 6; 6; 9; 6; 4; 6,
,,,tmVar:c|SUB|A|421|C;HGVS:c.421A>C;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179,SLCO1B1 (10599); ABCG2 (9429),,substitution,c.421A>C,unknown,30100615,0; 8,
,,,tmVar:rs4149056;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,unknown,rs4149056,unknown,30100615,6; 6; 6; 6; 6; 9; 6; 9; 6,
,,,tmVar:p|SUB|V|174|A;HGVS:p.V174A;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606;CA#:6476722,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,substitution,p.V174A,unknown,30100615,4; 4; 4; 4; 4; 6; 4; 6; 4,
,,,tmVar:c|SUB|C|421|A;HGVS:c.421C>A;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,substitution,c.421C>A,unknown,30100615,4; 4; 4; 4; 4; 4; 4; 4; 4,
,,,tmVar:rs2231142;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,unknown,rs2231142,unknown,30100615,0; 0; 0; 0; 0; 8; 0; 9; 0,
,,,tmVar:p|SUB|Q|141|K;HGVS:p.Q141K;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,substitution,p.Q141K,unknown,30100615,0; 0; 0; 0; 0; 0; 0; 0; 0,
,,,tmVar:c|Allele|C|521;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,unknown,c.521C,unknown,30100615,5; 5; 5; 5; 5; 9; 5; 9; 5,
,,,tmVar:c|Allele|CA|421;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,unknown,c.421CA,unknown,30100615,4; 4; 4; 4; 4; 7; 4; 7; 4,
,,,tmVar:c|Allele|A|421;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606,SLC10A2 (6555); ABCC2 (1244); AHR (196); FOXA3 (3171); RXRA (6256); SLCO1B1 (10599); HNF4A (3172); ABCG2 (9429); ABCB11 (8647),,unknown,c.421A,unknown,30100615,4; 4; 4; 4; 4; 8; 4; 8; 4,
,,,tmVar:rs10410870;VariantGroup:0;CorrespondingGene:3171;RS#:10410870;CorrespondingSpecies:9606,FOXA3 (3171); interleukin 10 (3586),SA (MESH:D050197); aortic valve calcification (MESH:C562942); atherosclerosis (MESH:D050197); magnesium deficiency (MESH:D008275); atherosclerotic lesions (MESH:D050197); insulin resistance (MESH:D007333),unknown,rs10410870,unknown,35625529,7; 6,7; 8; 6; 6; 6; 6
,,,tmVar:rs10412574;VariantGroup:1;CorrespondingGene:3171;RS#:10412574;CorrespondingSpecies:9606,FOXA3 (3171); interleukin 10 (3586),SA (MESH:D050197); aortic valve calcification (MESH:C562942); atherosclerosis (MESH:D050197); magnesium deficiency (MESH:D008275); atherosclerotic lesions (MESH:D050197); insulin resistance (MESH:D007333),unknown,rs10412574,unknown,35625529,7; 4,7; 0; 0; 7; 0; 8
,,,tmVar:rs6445583;VariantGroup:1;CorrespondingGene:776;RS#:6445583;CorrespondingSpecies:9606,CACNA1D (776); FOXA3 (3171); HECTD4 (283450),Resistant hypertension (MESH:D006973); BP (MESH:D006973); hypertension (MESH:D006973); resistant hypertension (MESH:D006973); resistance (MESH:D060467); blood pressure (MESH:D006973),unknown,rs6445583,unknown,37151119,8; 8; 8,10; 6; 6; 0; 4; 6
,,,tmVar:rs12308051;VariantGroup:3;RS#:12308051,CACNA1D (776); FOXA3 (3171); HECTD4 (283450),Resistant hypertension (MESH:D006973); BP (MESH:D006973); hypertension (MESH:D006973); resistant hypertension (MESH:D006973); resistance (MESH:D060467); blood pressure (MESH:D006973),unknown,rs12308051,unknown,37151119,4; 4; 4,8; 6; 6; 0; 4; 6
,,,tmVar:rs35497065;VariantGroup:2;CorrespondingGene:3171;RS#:35497065;CorrespondingSpecies:9606,CACNA1D (776); FOXA3 (3171); HECTD4 (283450),Resistant hypertension (MESH:D006973); BP (MESH:D006973); hypertension (MESH:D006973); resistant hypertension (MESH:D006973); resistance (MESH:D060467); blood pressure (MESH:D006973),unknown,rs35497065,unknown,37151119,4; 9; 0,8; 6; 5; 0; 5; 6
,,,tmVar:rs11066280;VariantGroup:0;CorrespondingGene:283450;RS#:11066280;CorrespondingSpecies:9606,CACNA1D (776); FOXA3 (3171); HECTD4 (283450),Resistant hypertension (MESH:D006973); BP (MESH:D006973); hypertension (MESH:D006973); resistant hypertension (MESH:D006973); resistance (MESH:D060467); blood pressure (MESH:D006973),unknown,rs11066280,unknown,37151119,6; 0; 10,8; 8; 8; 0; 6; 8
,,,tmVar:p|SUB|C|282|Y;HGVS:p.C282Y;VariantGroup:0;CorrespondingGene:3077;RS#:1800562;CorrespondingSpecies:9606;CA#:113795,HJV (148738); HFE 2 (148738); HFE (3077); HFE 1 (3077); AFP (174),HFE2 (MESH:C537247); iron overload (MESH:D019190); thrombocytopenia (MESH:D013921); juvenile hemochromatosis (MESH:C537247); hemochromatosis (MESH:D006432); genetic defect (MESH:D030342); diabetes mellitus (MESH:D003920); hepato- and splenomegaly (MESH:D013163); heptatocellular carcinoma (MESH:D009369); Non-HFE-hemochromatosis (MESH:D006432); liver cirrhosis (MESH:D008103); smallnodular liver cirrhosis (MESH:D008103); hyperpigmentation of the skin (MESH:D017495),substitution,p.C282Y,unknown,15942838,8; 9; 8; 6; 5,9; 9; 2; 9; 8; 8; 2; 2; 5; 9; 8; 8; 2
,,,tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797,HJV (148738); HFE 2 (148738); HFE (3077); HFE 1 (3077); AFP (174),HFE2 (MESH:C537247); iron overload (MESH:D019190); thrombocytopenia (MESH:D013921); juvenile hemochromatosis (MESH:C537247); hepatocellular carcinoma (MESH:D009369); hemochromatosis (MESH:D006432); genetic defect (MESH:D030342); diabetes mellitus (MESH:D003920); hepato- and splenomegaly (MESH:D013163); heptatocellular carcinoma (MESH:D009369); Non-HFE-hemochromatosis (MESH:D006432); liver cirrhosis (MESH:D008103); smallnodular liver cirrhosis (MESH:D008103); hyperpigmentation of the skin (MESH:D017495),substitution,p.H63D,unknown,15942838,8; 8; 4; 6; 0,0; 8; 3; 8; 3; 8; 6; 3; 3; 0; 8; 8; 6; 3
,,,tmVar:rs17222089;VariantGroup:1;CorrespondingGene:5800;RS#:17222089;CorrespondingSpecies:9606,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs17222089,unknown,22126837,10; 10; 10; 10,0; 7; 0
,,,tmVar:rs11056571;VariantGroup:3;CorrespondingGene:5800;RS#:11056571;CorrespondingSpecies:9606,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs11056571,unknown,22126837,0; 0; 0; 0,0; 0; 0
,,,tmVar:rs2300290;VariantGroup:5;CorrespondingGene:5800;RS#:2300290;CorrespondingSpecies:9606,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs2300290,unknown,22126837,6; 6; 10; 10,0; 8; 0
,,,tmVar:rs719714;VariantGroup:4;RS#:719714,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs719714,unknown,22126837,0; 0; 10; 8,0; 6; 0
,,,tmVar:rs9378605;VariantGroup:2;RS#:9378605,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs9378605,unknown,22126837,8; 8; 6; 4,0; 8; 0
,,,tmVar:rs11699311;VariantGroup:0;RS#:11699311,FOXQ1 (94234); SUMO1P1 (391257); PTPRO (5800); WDR72 (256764),schizophrenia spectrum disorder (MESH:D019967); speed (MESH:D008569); bipolar disorder (MESH:D001714),unknown,rs11699311,unknown,22126837,9; 9; 9; 8,0; 8; 0
,,,tmVar:c|SUB|C|-33|A;HGVS:c.-33C>A;VariantGroup:0,FOXQ1 (94234); RAD51B (5890); IL-28A (282616); CASP3 (836),cervical cancer (MESH:D002583),substitution,c.-33C>A,unknown,27363024,6; 6; 6; 6,8
,,,tmVar:rs616488;VariantGroup:4;CorrespondingGene:5195;RS#:616488;CorrespondingSpecies:9606,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs616488,unknown,27859137,8; 8; 8; 8; 8,0; 9
,,,tmVar:rs11242675;VariantGroup:5;RS#:11242675,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs11242675,unknown,27859137,7; 7; 8; 6; 7,0; 0
,,,tmVar:rs6001930;VariantGroup:2;CorrespondingGene:57591;RS#:6001930;CorrespondingSpecies:9606,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs6001930,unknown,27859137,8; 0; 5; 0; 5,0; 0
,,,tmVar:rs1353747;VariantGroup:1;CorrespondingGene:5144;RS#:1353747;CorrespondingSpecies:9606,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs1353747,unknown,27859137,7; 8; 7; 8; 7,4; 0
,,,tmVar:rs6472903;VariantGroup:3;RS#:6472903,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs6472903,unknown,27859137,4; 4; 4; 0; 4,0; 0
,,,tmVar:rs204247;VariantGroup:0;RS#:204247,MKL1 (57591); PDE4D (5144); FOXQ1 (94234); RANBP9 (10048); PEX14 (5195),breast cancers (MESH:D001943); breast cancer (MESH:D001943),unknown,rs204247,unknown,27859137,6; 8; 6; 8; 6,0; 0
,,,tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:9606;CA#:127791,p21 (644914); SIRT1 (23411); FOXQ1 (94234); p53 (7157); PCNA (5111); p16 (1029),tumor (MESH:D009369); neurodegenerative diseases (MESH:D019636); Alzheimer's disease (MESH:D000544); AD (MESH:D000544),substitution,p.V717I,unknown,29500491,0; 4; 6; 0; 4; 0,0; 0; 9; 9
,,,tmVar:rs1108010;VariantGroup:1;CorrespondingGene:387755;RS#:1108010;CorrespondingSpecies:9606,INSC (387755); GRIK2 (2898); NKAIN2 (154215); BAALC (79870); CLTA (1211); GBP3 (2635); CCDC146 (57639); FOXD2 (2306); GBP1 (2633),Dementia (MESH:D003704); Alzheimer's disease (MESH:D000544); AD (MESH:D000544); Alzheimer's Disease (MESH:D000544),unknown,rs1108010,unknown,34224794,10; 0; 0; 3; 3; 0; 0; 3; 0,0; 7; 7; 0
,,,tmVar:rs7931705;VariantGroup:0;RS#:7931705,INSC (387755); GRIK2 (2898); NKAIN2 (154215); BAALC (79870); CLTA (1211); GBP3 (2635); CCDC146 (57639); FOXD2 (2306); GBP1 (2633),Dementia (MESH:D003704); Alzheimer's disease (MESH:D000544); AD (MESH:D000544); Alzheimer's Disease (MESH:D000544),unknown,rs7931705,unknown,34224794,9; 0; 0; 0; 4; 0; 0; 4; 0,0; 0; 0; 0
,,,tmVar:c|SUB|G|85|C;HGVS:c.85G>C;VariantGroup:1;CorrespondingGene:5172;RS#:111033205;CorrespondingSpecies:9606;CA#:253315,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,c.85G>C,unknown,36499699,8; 0; 8; 0; 6; 6,8; 8; 8; 7; 0; 0; 6; 0; 0
,,,tmVar:p|SUB|E|29|Q;HGVS:p.E29Q;VariantGroup:1;CorrespondingGene:5172;RS#:111033205;CorrespondingSpecies:9606;CA#:253315,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,p.E29Q,unknown,36499699,9; 0; 8; 0; 6; 6,9; 9; 8; 4; 0; 6; 6; 6; 0
,,,tmVar:c|SUB|A|757|G;HGVS:c.757A>G;VariantGroup:2;CorrespondingGene:5172;RS#:773657545;CorrespondingSpecies:9606;CA#:4432558,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,c.757A>G,unknown,36499699,8; 0; 9; 0; 6; 6,0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|I|253|V;HGVS:p.I253V;VariantGroup:2;CorrespondingGene:5172;RS#:773657545;CorrespondingSpecies:9606;CA#:4432558,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,p.I253V,unknown,36499699,0; 0; 0; 0; 0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:c|SUB|T|2027|A;HGVS:c.2027T>A;VariantGroup:0;CorrespondingGene:5172;RS#:111033318;CorrespondingSpecies:9606;CA#:261424,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); hearing loss (HL) (MESH:D034381); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,c.2027T>A,unknown,36499699,8; 0; 9; 0; 0; 0,0; 8; 8; 6; 7; 8; 0; 7; 0; 8
,,,tmVar:p|SUB|L|676|Q;HGVS:p.L676Q;VariantGroup:0;CorrespondingGene:5172;RS#:111033318;CorrespondingSpecies:9606;CA#:261424,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,p.L676Q,unknown,36499699,0; 0; 0; 0; 0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:c|SUB|G|2089+1|A;HGVS:c.2089+1G>A;VariantGroup:4;CorrespondingGene:5172;RS#:727503430(Expired);CorrespondingSpecies:9606;CA#:273227,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),DFNB4 (5172); hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); hearing loss (HL) (MESH:D034381); IP-1 (8517); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638); IP-2 (8517),substitution,c.2089+1G>A,unknown,36499699,0; 2; 9; 2; 0; 0,9; 0; 8; 8; 8; 6; 8; 6; 6; 8; 6; 8; 6
,,,tmVar:c|SUB|G|IVS18+1|A;HGVS:c.IVS18+1G>A;VariantGroup:5;CorrespondingGene:5172;CorrespondingSpecies:9606,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); hearing loss (HL) (MESH:D034381); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,c.IVS18+1G>A,unknown,36499699,8; 1; 8; 1; 5; 5,0; 0; 8; 8; 8; 8; 0; 8; 0; 8
,,,tmVar:c|SUB|G|441|A;HGVS:c.441G>A;VariantGroup:3;CorrespondingGene:5172;RS#:201905280;CorrespondingSpecies:9606;CA#:4432482,"DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); In cases with cochleovestibular malformations, molecular genetic analysis of the coding regions of the SLC26A4, FOXI1, and KCNJ10 genes associated with DFNB4 was completed. (5172); KCNJ10 (3766); IP-1 (8517); Sequencing of the SLC26A4, FOXI1, and KCNJ10 genes was performed in these six patients. (2299); Sequencing of the SLC26A4, FOXI1, and KCNJ10 genes was performed in these six patients. (3766); Pathogenic variants in the SLC26A4, FOXI1, and KCNJ10 genes are associated with hearing loss (HL) and specific inner ear abnormalities (DFNB4). (5172); IP-2 (8517)","hearing loss (MESH:D034381); in the SLC26A4 gene, we identified four variants, namely c.85G>C p.(Glu29Gln), c.757A>G p.(Ile253Val), c.2027T>A p.(Leu676Gln), and c.2089+1G>A (IVS18+1G>A), which are known as pathogenic, as well as c.441G>A p.(Met147Ile), reported previously as a variant with uncertain significance. (506); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638); The contribution of biallelic SLC26A4 variants in patients with IP-1, IP-2, IP-2+EVA, and isolated EVA was 66.7% (DFNB4 in three patients, Pendred syndrome in one patient). (MESH:D034381)",substitution,c.441G>A,unknown,36499699,7; 0; 0; 6; 0; 0; 4; 4; 6; 0,6; 9; 0; 0; 4; 0; 0; 0; 0; 0; 5
,,,tmVar:p|SUB|M|147|I;HGVS:p.M147I;VariantGroup:3;CorrespondingGene:5172;RS#:201905280;CorrespondingSpecies:9606;CA#:4432482,DFNB4 (5172); FOXI1 (2299); SLC26A4 (5172); KCNJ10 (3766); IP-1 (8517); IP-2 (8517),hearing loss (MESH:D034381); HL (MESH:D034381); inner ear abnormalities (MESH:D007759); Pendred syndrome (MESH:C536648); cochleovestibular malformations (MESH:C564254); IP-2 anomaly (MESH:D007184); enlarged vestibular aqueduct (EVA) anomaly (OMIM:600791); IP-2+ (MESH:D007184); deaf (MESH:D003638),substitution,p.M147I,unknown,36499699,0; 2; 8; 2; 0; 0,9; 9; 8; 4; 4; 4; 6; 4; 4
,,,tmVar:c|DEL|470|;HGVS:c.470del;VariantGroup:2;CorrespondingGene:540;CorrespondingSpecies:9606,ceruloplasmin (1356); ATP7B (540); SLC4A1 (6521); ATP6V1B1 (525); FOXI1 (2299); ATP6V0A4 (50617); WDR72 (256764),Fanconi syndrome (MESH:D005198); wrist widening (MESH:D014954); glucosuria (MESH:D006030); RTA (MESH:D000141); rickets (MESH:D012279); hypercalciuria (MESH:D053565); phosphaturia (MESH:D007015); rigidity (MESH:D009127); Wilson disease (MESH:D006527); hepatic or neurological involvement (MESH:D009461); metabolic acidosis (MESH:D000138); renal tubular acidosis (MESH:D000141); cognitive and speech impairment (MESH:D003072); genu varum (MESH:D056305); distal renal tubular involvement (MESH:D000141); aminoaciduria (MESH:D000608); hypokalemia (MESH:D007008),deletion,c.470del,unknown,37415038,6; 10; 0; 0; 0; 0; 0,0; 4; 0; 6; 4; 4; 0; 4; 10; 4; 6; 0; 4; 4; 0; 0; 6
,,,tmVar:c|SUB|G|1078|A;HGVS:c.1078G>A;VariantGroup:1;CorrespondingGene:64699;RS#:1251706736;CorrespondingSpecies:9606,LRTOMT (220074); FOXI1 (2299); GJB2 (2706); TMPRSS3 (64699),non-syndromic hereditary deafness (MESH:D003123); hearing loss (MESH:D034381); deafness (MESH:D003638); presbycusis (MESH:D011304); autosomal recessive non-syndromic hearing loss (OMIM:600791); sensorineural disorders (MESH:D006319); deaf (MESH:D003638); ARNSHL (OMIM:600791),substitution,c.1078G>A,unknown,37777971,8; 9; 8; 9,6; 6; 6; 0; 0; 0; 6; 0
,,,tmVar:p|SUB|A|360|T;HGVS:p.A360T;VariantGroup:1;CorrespondingGene:64699;RS#:1251706736;CorrespondingSpecies:9606,LRTOMT (220074); FOXI1 (2299); GJB2 (2706); TMPRSS3 (64699),non-syndromic hereditary deafness (MESH:D003123); hearing loss (MESH:D034381); deafness (MESH:D003638); presbycusis (MESH:D011304); autosomal recessive non-syndromic hearing loss (OMIM:600791); sensorineural disorders (MESH:D006319); deaf (MESH:D003638); ARNSHL (OMIM:600791),substitution,p.A360T,unknown,37777971,3; 10; 3; 10,8; 4; 4; 0; 8; 0; 0; 8
,,,tmVar:c|SUB|C|6|G;HGVS:c.6C>G;VariantGroup:0;CorrespondingGene:220074;RS#:1405455306;CorrespondingSpecies:9606,LRTOMT (220074); FOXI1 (2299); GJB2 (2706); TMPRSS3 (64699),non-syndromic hereditary deafness (MESH:D003123); hearing loss (MESH:D034381); deafness (MESH:D003638); presbycusis (MESH:D011304); autosomal recessive non-syndromic hearing loss (OMIM:600791); sensorineural disorders (MESH:D006319); deaf (MESH:D003638); ARNSHL (OMIM:600791),substitution,c.6C>G,unknown,37777971,8; 8; 6; 0,6; 7; 7; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|S|2|R;HGVS:p.S2R;VariantGroup:2;CorrespondingGene:2299;CorrespondingSpecies:9606,LRTOMT (220074); FOXI1 (2299); GJB2 (2706); TMPRSS3 (64699),non-syndromic hereditary deafness (MESH:D003123); hearing loss (MESH:D034381); deafness (MESH:D003638); presbycusis (MESH:D011304); autosomal recessive non-syndromic hearing loss (OMIM:600791); sensorineural disorders (MESH:D006319); deaf (MESH:D003638); ARNSHL (OMIM:600791),substitution,p.S2R,unknown,37777971,7; 8; 7; 6,5; 4; 4; 0; 5; 0; 4; 0
,,,tmVar:p|SUB|F|170|S;HGVS:p.F170S;VariantGroup:0;CorrespondingGene:836;CorrespondingSpecies:9606,NF-kappaB (4790); caspase 3 (836); IRF (84676); FOXD1 (2297),croup (MESH:D003440); HPIV1 infection (MESH:D018184),substitution,p.F170S,unknown,19052086,4; 5; 4; 3,3; 8
,,,tmVar:c|SUB|C|-824|T;HGVS:c.-824C>T;VariantGroup:2;CorrespondingGene:7054;RS#:10770141;CorrespondingSpecies:9606;CA#:13514699,me myocyte enhancer factor-2 (4205); TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,c.-824C>T,unknown,20124442,6; 8; 5; 0; 5; 6; 5; 8; 8; 8; 5; 0; 6; 8,
,,,tmVar:c|SUB|G|-801|C;HGVS:c.-801G>C;VariantGroup:3;CorrespondingGene:7054;RS#:10840490;CorrespondingSpecies:9606;CA#:13567348,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,c.-801G>C,unknown,20124442,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0,
,,,tmVar:c|SUB|A|-581|G;HGVS:c.-581A>G;VariantGroup:0;CorrespondingGene:7054;RS#:10770140;CorrespondingSpecies:9606;CA#:13370133,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,c.-581A>G,unknown,20124442,8; 7; 6; 7; 4; 6; 8; 5; 7; 6; 0; 4; 5,
,,,tmVar:c|SUB|G|-494|A;HGVS:c.-494G>A;VariantGroup:1;CorrespondingGene:7054;RS#:11042962;CorrespondingSpecies:9606;CA#:13370132,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,c.-494G>A,unknown,20124442,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0,
,,,tmVar:c|SUB|G||C;VariantGroup:4;CorrespondingGene:2297;CorrespondingSpecies:9606,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,G/C,unknown,20124442,8; 5; 6; 5; 6; 5; 8; 6; 6; 5; 0; 6; 6,
,,,tmVar:c|SUB|T||C;VariantGroup:6;CorrespondingGene:4205;CorrespondingSpecies:9606,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,T>C,unknown,20124442,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0,
,,,tmVar:c|SUB|G||A;VariantGroup:5;CorrespondingGene:1958;CorrespondingSpecies:9606,TH (7054); EGR1 (1958); myocyte enhancer factor-2 (4205); AP2 (7020); sex-determining region Y (6736); activating enhancer-binding protein 2 (7020); Tyrosine hydroxylase (7054); FOXD1 (2297); MEF2 (4205); early growth response protein 1 (1958); specificity protein 1 (6667); forkhead box D1 (2297); SRY (6736),,substitution,G>A,unknown,20124442,8; 4; 7; 4; 6; 0; 8; 4; 4; 0; 0; 6; 4,
,,,tmVar:p|SUB|T|41|A;HGVS:p.T41A;VariantGroup:0;CorrespondingGene:1499;RS#:121913412;CorrespondingSpecies:9606;CA#:74088767,WT1 (7490); PAX3 (5077); SIX1 (6495); IGF2 (3481); FOXD1 (2297); MEIS1 (4211); OSR2 (116039); OSR1 (130497); CTNNB1 (1499),anaplasia (MESH:D000708); uniparental disomy (MESH:D024182); Wilms tumors (MESH:D009396); tumor (MESH:D009369); Uniparental disomy (MESH:D024182); UPD (MESH:D024182); Wilms tumor (MESH:D009396),substitution,p.T41A,unknown,27213811,9; 0; 0; 8; 0; 0; 0; 0; 6,7; 8; 0; 8; 0; 8; 9
,,,tmVar:c|SUB|C|800|G;HGVS:c.800C>G;VariantGroup:0,BAP1 (8314); FOXK1 (221937); Forkhead-box K1 (221937),familial MPM (MESH:D000086002); Malignant pleural mesothelioma (MESH:D000086002); tumor (MESH:D009369); MPM carcinogenic (MESH:D000086002); MPM (MESH:D000086002),substitution,c.800C>G,unknown,30408567,5; 6; 6,5; 9; 4; 5; 9
,,,tmVar:rs11064685;VariantGroup:0;CorrespondingGene:84530;RS#:11064685;CorrespondingSpecies:9606,CDH5 (1003); SDK1 (221935); DNAH17 (8632); FOXK1 (221937); GABBR2 (9568); CNTN5 (53942); DPP10 (57628); SNCA (6622); DSCAM (1826); NTM (50863); SRRM4 (84530); CNTNAP5 (129684); ITPR1 (3708),Autism spectrum disorder (MESH:D000067877); Autism spectrum disorder (ASD) (MESH:D000067877); ASD (MESH:D000067877),unknown,rs11064685,unknown,32807774,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 8; 0; 0,0; 4; 4
,,,tmVar:p|SUB|G|44|D;HGVS:p.G44D;VariantGroup:0;CorrespondingGene:9968;RS#:199469672;CorrespondingSpecies:9606;CA#:145569,Cut Like Homeobox 1 (1523); MED12 (9968); Mediator complex subunit 12 (9968); FOXK1 (221937); CUX1 (1523); cyclin dependent kinase 8/19 (1024;23097); CDK8 (1024); Forkhead Box K1 (221937); CDK8/19 (1024;23097),uterine fibroids (MESH:D007889); uterine fibroid (MESH:D007889),substitution,p.G44D,unknown,35559861,7; 9; 9; 7; 7; 6; 5; 7; 6,0; 0
,,,tmVar:c|SUB|T|-103|C;HGVS:c.-103T>C;VariantGroup:0;OriginalGene:23985;CorrespondingGene:5172;RS#:60284988;CorrespondingSpecies:10090;CA#:253314,FOXI1 (2299); Foxi1 (14233); SLC26A4 (5172); Slc26a4 (23985); SLC26A4 (23985),EVA (OMIM:600791); PS (MESH:C536648); DFNB4 (OMIM:600791); Pendred syndrome (MESH:C536648); enlarged vestibular aqueduct (OMIM:600791); nonsyndromic hearing loss (MESH:C580334); nonsyndromic EVA (OMIM:600791),substitution,c.-103T>C,unknown,17503324,9; 4; 8; 0; 4,0; 6; 0; 6; 7; 5; 0
,,,tmVar:p|Allele|M|241;VariantGroup:0;OriginalGene:17126;CorrespondingGene:4087;CorrespondingSpecies:10090,TGFbeta (21803); Smad2 (17126); Nodal (18119); Mad (17119),,translocation,initiation at Met(241,unknown,18764783,8; 10; 4; 0,
,,,tmVar:c|SUB|G|-2554|A;HGVS:c.-2554G>A;VariantGroup:1;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299),goiters (MESH:D006042); EVA (OMIM:600791); nonsyndromic enlarged vestibular aqueduct (OMIM:600791); Pendred syndrome (MESH:C536648); nonsyndromic EVA (OMIM:600791),substitution,c.-2554G>A,unknown,19648736,0; 0,0; 0; 0; 0; 0
,,,tmVar:c|SUB|A|919-2|G;HGVS:c.919-2A>G;VariantGroup:0;CorrespondingGene:5172;RS#:111033313;CorrespondingSpecies:9606;CA#:261445,SLC26A4 (5172); FOXI1 (2299),goiters (MESH:D006042); EVA (OMIM:600791); nonsyndromic enlarged vestibular aqueduct (OMIM:600791); Pendred syndrome (MESH:C536648); nonsyndromic EVA (OMIM:600791),substitution,c.919-2A>G,unknown,19648736,4; 0,0; 6; 6; 6; 6
,,,tmVar:p|SUB|M|147|I;HGVS:p.M147I;VariantGroup:1;CorrespondingGene:5172;RS#:201905280;CorrespondingSpecies:9606;CA#:4432482,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),unilateral deafness (MESH:D046088); Mondini dysplasia (MESH:D015792); Enlargement of the vestibular aqueduct (OMIM:600791); Pendred syndrome (MESH:C536648); enlarged vestibular aqueduct (OMIM:600791); inner ear malformation (MESH:D007759); unilateral hearing impairment (MESH:D046088),substitution,p.M147I,unknown,20621367,8; 3; 3,0; 0; 6; 0; 0; 6; 6
,,,tmVar:p|SUB|N|538|N;HGVS:p.N538N;VariantGroup:0;CorrespondingGene:5172;RS#:111033193;CorrespondingSpecies:9606;CA#:132671,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),unilateral deafness (MESH:D046088); Mondini dysplasia (MESH:D015792); Enlargement of the vestibular aqueduct (OMIM:600791); Pendred syndrome (MESH:C536648); enlarged vestibular aqueduct (OMIM:600791); inner ear malformation (MESH:D007759); unilateral hearing impairment (MESH:D046088),substitution,p.N538N,unknown,20621367,0; 0; 0,0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|L|627|R;HGVS:p.L627R;VariantGroup:2;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),unilateral deafness (MESH:D046088); Mondini dysplasia (MESH:D015792); Enlargement of the vestibular aqueduct (OMIM:600791); Pendred syndrome (MESH:C536648); enlarged vestibular aqueduct (OMIM:600791); inner ear malformation (MESH:D007759); unilateral hearing impairment (MESH:D046088),substitution,p.L627R,unknown,20621367,9; 4; 4,0; 0; 9; 0; 0; 8; 9
,,,tmVar:p|SUB|T|485|M;HGVS:p.T485M;VariantGroup:0;CorrespondingGene:5172;RS#:370029782;CorrespondingSpecies:9606;CA#:4432828,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),Pendred syndrome (MESH:C536648); nonsyndromic enlargement of the vestibular aqueduct (OMIM:600791); enlarged vestibular aqueduct (OMIM:600791); hearing-impaired (MESH:D034381); sensorineural hearing loss (MESH:D006319),substitution,p.T485M,unknown,21366435,7; 4; 4,7; 7; 7; 6; 6
,,,tmVar:p|SUB|F|718|S;HGVS:p.F718S;VariantGroup:1;CorrespondingGene:5172;RS#:750834241;CorrespondingSpecies:9606;CA#:4433060,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),Pendred syndrome (MESH:C536648); nonsyndromic enlargement of the vestibular aqueduct (OMIM:600791); enlarged vestibular aqueduct (OMIM:600791); hearing-impaired (MESH:D034381); sensorineural hearing loss (MESH:D006319),substitution,p.F718S,unknown,21366435,8; 0; 0,0; 0; 0; 0; 0
,,,tmVar:c|SUB|A|IVS7-2|G;HGVS:c.IVS7-2A>G;VariantGroup:1;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299),nonsyndromic hearing loss (MESH:C580334); enlarged vestibular aqueduct (OMIM:600791),substitution,c.IVS7-2A>G,unknown,22289209,8; 5,7; 8
,,,tmVar:p|SUB|H|723|R;HGVS:p.H723R;VariantGroup:0;CorrespondingGene:5172;RS#:121908362;CorrespondingSpecies:9606;CA#:253307,SLC26A4 (5172); FOXI1 (2299),nonsyndromic hearing loss (MESH:C580334); enlarged vestibular aqueduct (OMIM:600791),substitution,p.H723R,unknown,22289209,8; 4,6; 6
,,,tmVar:c|INS|662_663|G;HGVS:c.662_663insG;VariantGroup:0;CorrespondingGene:5172;CorrespondingSpecies:9606,FOXI1 (2299); pendrin (5172); SLC26A4 (5172); KCNJ10 (3766); GJB2 (2706),hereditary determined diseases (MESH:D030342); sensorineural hearing impairment (MESH:D006319); Pendred syndrome (MESH:C536648),insertion,c.662_663insG,unknown,22906308,0; 8; 9; 0; 0,4; 4; 10
,,,tmVar:c|SUB|A|IVS7-2|G;HGVS:c.IVS7-2A>G;VariantGroup:1;CorrespondingGene:5172;CorrespondingSpecies:9606,FOXI1 (2299); pendrin (5172); SLC26A4 (5172); KCNJ10 (3766); GJB2 (2706),hereditary determined diseases (MESH:D030342); sensorineural hearing impairment (MESH:D006319); Pendred syndrome (MESH:C536648),substitution,c.IVS7-2A>G,unknown,22906308,0; 8; 10; 0; 0,4; 4; 9
,,,tmVar:c|SUB|G|-1606|A;HGVS:c.-1606G>A;VariantGroup:3;CorrespondingGene:3659;CorrespondingSpecies:9606,NPY2R (18167); neuropeptide Y (4852); FOXI1 (2299); IRF1 (3659); NPY2R. (4887); PYY (5697); neuropeptide Y(2) G-protein-coupled receptor (4887); NPY2R (66024); SNAI1 (6615); NPY2R (4887),metabolic syndrome (MESH:D024821); hypertensive (MESH:D006973); obesity (MESH:D009765); hypertension (MESH:D006973),substitution,c.-1606G>A,unknown,23149563,0; 0; 5; 5; 0; 7; 7; 0; 5; 8,0; 0; 7; 0
,,,tmVar:c|SUB|C|-599|T;HGVS:c.-599C>T;VariantGroup:1;OriginalGene:66024;CorrespondingGene:4887;RS#:6857715;CorrespondingSpecies:10116;CA#:11704953,NPY2R (18167); neuropeptide Y (4852); FOXI1 (2299); IRF1 (3659); NPY2R. (4887); PYY (5697); neuropeptide Y(2) G-protein-coupled receptor (4887); NPY2R (66024); SNAI1 (6615); NPY2R (4887),metabolic syndrome (MESH:D024821); hypertensive (MESH:D006973); obesity (MESH:D009765); hypertension (MESH:D006973),substitution,c.-599C>T,unknown,23149563,0; 0; 0; 0; 0; 0; 0; 0; 0; 0,0; 0; 0; 0
,,,tmVar:c|SUB|A|-224|G;HGVS:c.-224A>G;VariantGroup:0;CorrespondingGene:4852;RS#:1412111672;CorrespondingSpecies:9606,NPY2R (18167); neuropeptide Y (4852); FOXI1 (2299); IRF1 (3659); NPY2R. (4887); PYY (5697); neuropeptide Y(2) G-protein-coupled receptor (4887); NPY2R (66024); SNAI1 (6615); NPY2R (4887),metabolic syndrome (MESH:D024821); hypertensive (MESH:D006973); obesity (MESH:D009765); hypertension (MESH:D006973),substitution,c.-224A>G,unknown,23149563,0; 2; 8; 8; 0; 3; 7; 0; 8; 9,4; 0; 7; 4
,,,tmVar:c|SUB|A||G;VariantGroup:2;CorrespondingGene:3659;CorrespondingSpecies:9606,NPY2R (18167); neuropeptide Y (4852); FOXI1 (2299); IRF1 (3659); NPY2R. (4887); PYY (5697); neuropeptide Y(2) G-protein-coupled receptor (4887); NPY2R (66024); SNAI1 (6615); NPY2R (4887),metabolic syndrome (MESH:D024821); hypertensive (MESH:D006973); obesity (MESH:D009765); hypertension (MESH:D006973),substitution,A>G,unknown,23149563,0; 0; 6; 6; 0; 4; 8; 0; 6; 9,4; 0; 9; 4
,,,tmVar:c|SUB|T||C;VariantGroup:4;CorrespondingGene:2299;CorrespondingSpecies:9606,NPY2R (18167); neuropeptide Y (4852); FOXI1 (2299); IRF1 (3659); NPY2R. (4887); PYY (5697); neuropeptide Y(2) G-protein-coupled receptor (4887); NPY2R (66024); SNAI1 (6615); NPY2R (4887),metabolic syndrome (MESH:D024821); hypertensive (MESH:D006973); obesity (MESH:D009765); hypertension (MESH:D006973),substitution,T>C,unknown,23149563,0; 0; 0; 0; 0; 0; 0; 0; 0; 0,0; 0; 0; 0
,,,tmVar:p|SUB|R|271|C;HGVS:p.R271C;VariantGroup:1;CorrespondingGene:3766;RS#:1130183;CorrespondingSpecies:9606;CA#:288916,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),sensorineural hearing impairment (MESH:D006319); Mondini dysplasia (MESH:D015792); EVA (OMIM:600791); goitre (MESH:D006042); autosomal recessive disorder (MESH:D030342); Pendred syndrome (MESH:C536648); epilepsy (MESH:D004827); seizure (MESH:D012640); Hearing impairment (MESH:D034381); enlarged vestibular aqueducts (OMIM:600791); thyroid dyshormonogensis (MESH:D013966); deafness (MESH:D003638); non-syndromic EVA (OMIM:600791),substitution,p.R271C,unknown,23965030,0; 0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|R|18|Q;HGVS:p.R18Q;VariantGroup:0;CorrespondingGene:3766;RS#:115466046;CorrespondingSpecies:9606;CA#:288914,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),sensorineural hearing impairment (MESH:D006319); Mondini dysplasia (MESH:D015792); EVA (OMIM:600791); goitre (MESH:D006042); autosomal recessive disorder (MESH:D030342); Pendred syndrome (MESH:C536648); epilepsy (MESH:D004827); seizure (MESH:D012640); Hearing impairment (MESH:D034381); enlarged vestibular aqueducts (OMIM:600791); enlarged vestibular aqueducts (EVA) (OMIM:600791); thyroid dyshormonogensis (MESH:D013966); deafness (MESH:D003638); non-syndromic EVA (OMIM:600791),substitution,p.R18Q,unknown,23965030,8; 0; 6,5; 5; 5; 5; 0; 9; 0; 0; 5; 0; 5; 5; 5; 5
,,,tmVar:p|SUB|R|123|W;HGVS:p.R123W;VariantGroup:2;CorrespondingGene:2299;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),sensorineural hearing impairment (MESH:D006319); Mondini dysplasia (MESH:D015792); EVA (OMIM:600791); goitre (MESH:D006042); autosomal recessive disorder (MESH:D030342); Pendred syndrome (MESH:C536648); epilepsy (MESH:D004827); seizure (MESH:D012640); Hearing impairment (MESH:D034381); enlarged vestibular aqueducts (OMIM:600791); thyroid dyshormonogensis (MESH:D013966); deafness (MESH:D003638); non-syndromic EVA (OMIM:600791),substitution,p.R123W,unknown,23965030,0; 0; 0,0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0; 0
,,,tmVar:p|SUB|H|723|R;HGVS:p.H723R;VariantGroup:0;CorrespondingGene:5172;RS#:121908362;CorrespondingSpecies:9606;CA#:253307,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),Cochlear malformation (MESH:D015834); Enlarged vestibular aqueduct (OMIM:600791); EVA (OMIM:600791); hearing loss (MESH:D034381),substitution,p.H723R,unknown,24338212,0; 0; 0,0; 0; 0; 0
,,,tmVar:c|SUB|A|IVS7-2|G;HGVS:c.IVS7-2A>G;VariantGroup:1;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),Cochlear malformation (MESH:D015834); Enlarged vestibular aqueduct (OMIM:600791); EVA (OMIM:600791); hearing loss (MESH:D034381),substitution,c.IVS7-2A>G,unknown,24338212,0; 0; 0,0; 0; 0; 0
,,,tmVar:c|DEL|923_929|;HGVS:c.923_929del;VariantGroup:1;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),EVA (OMIM:600791); sensorineural deafness (MESH:D006319); Enlarged vestibular aqueduct (OMIM:600791); genetic defects (MESH:D030342); Enlarged vestibular aqueduct (EVA) (OMIM:600791); inner ear malformations (MESH:D007759),deletion,c.923_929del,unknown,27997596,8; 7; 0,8; 0; 0; 0; 8; 0
,,,tmVar:c|SUB|C|1002-8|G;HGVS:c.1002-8C>G;VariantGroup:2;CorrespondingGene:2299;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),EVA (OMIM:600791); sensorineural deafness (MESH:D006319); Enlarged vestibular aqueduct (OMIM:600791); genetic defects (MESH:D030342); inner ear malformations (MESH:D007759),substitution,c.1002-8C>G,unknown,27997596,9; 6; 5,9; 5; 9; 5; 5
,,,tmVar:c|SUB|C|519|A;HGVS:c.519C>A;VariantGroup:0;CorrespondingGene:2299;CorrespondingSpecies:9606,FOXI1 (2299); SLC26A4 (5172); Ensembl: ENSG00000122192 (5172); ENSG00000105870 (2299); KCNJ10 (3766),EVA (OMIM:600791); sensorineural deafness (MESH:D006319); Enlarged vestibular aqueduct (OMIM:600791); genetic defects (MESH:D030342); inner ear malformations (MESH:D007759),substitution,c.519C>A,unknown,27997596,0; 0; 7; 7; 0,8; 0; 8; 6; 0
,,,tmVar:p|SUB|L|146|F;HGVS:p.L146F;VariantGroup:0;CorrespondingGene:2299;CorrespondingSpecies:9606,FOXI1 (2299),sensorineural deafness (MESH:D006319); distal renal tubular acidosis (MESH:D000141),substitution,p.L146F,unknown,29242249,8,7; 7
,,,tmVar:p|SUB|R|213|P;HGVS:p.R213P;VariantGroup:1;CorrespondingGene:2299;CorrespondingSpecies:9606,FOXI1 (2299),sensorineural deafness (MESH:D006319); distal renal tubular acidosis (MESH:D000141),substitution,p.R213P,unknown,29242249,6,8; 0
,,,tmVar:c|SUB|A|919-2|G;HGVS:c.919-2A>G;VariantGroup:0;CorrespondingGene:5172;RS#:111033313;CorrespondingSpecies:9606;CA#:261445,FOX1 (2299); FOXI1 (2299); EYA1 (2138); SLC26A4 (5172); KCNJ10 (3766); DFNB4 (5172),sensorineural hearing impairment (MESH:D006319); autosomal-recessive disorders (MESH:D030342); EVA (OMIM:600791); Pendred syndrome (MESH:C536648); nonsyndromic autosomal recessive deafness-4 (OMIM:600791); inner-ear malformation (MESH:D007759); Enlarged vestibular aqueduct (OMIM:600791),substitution,c.919-2A>G,unknown,30268946,5; 0; 4; 6; 5; 8,4; 4; 0; 7; 8; 4; 8
,,,tmVar:p|SUB|H|723|R;HGVS:p.H723R;VariantGroup:1;CorrespondingGene:5172;RS#:121908362;CorrespondingSpecies:9606;CA#:253307,FOX1 (2299); FOXI1 (2299); EYA1 (2138); SLC26A4 (5172); KCNJ10 (3766); DFNB4 (5172),sensorineural hearing impairment (MESH:D006319); autosomal-recessive disorders (MESH:D030342); EVA (OMIM:600791); Pendred syndrome (MESH:C536648); nonsyndromic autosomal recessive deafness-4 (OMIM:600791); inner-ear malformation (MESH:D007759); Enlarged vestibular aqueduct (OMIM:600791),substitution,p.H723R,unknown,30268946,2; 2; 1; 6; 2; 6,4; 4; 6; 6; 6; 4; 6
,,,tmVar:c|SUB|G|812|A;HGVS:c.812G>A;VariantGroup:1;CorrespondingGene:3766;RS#:3795339;CorrespondingSpecies:9606;CA#:288918,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),neonatal deafness (MESH:D003638); hearing loss (MESH:D034381),substitution,c.812G>A,unknown,31243244,9; 4; 6,7; 0
,,,tmVar:c|SUB|A|800|G;HGVS:c.800A>G;VariantGroup:2;CorrespondingGene:2299;RS#:3828625;CorrespondingSpecies:9606;CA#:3555165,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),neonatal deafness (MESH:D003638); hearing loss (MESH:D034381),substitution,c.800A>G,unknown,31243244,9; 4; 8,4; 6
,,,tmVar:c|SUB|G|53|A;HGVS:c.53G>A;VariantGroup:3;CorrespondingGene:3766;RS#:115466046;CorrespondingSpecies:9606;CA#:288914,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),neonatal deafness (MESH:D003638); hearing loss (MESH:D034381),substitution,c.53G>A,unknown,31243244,9; 4; 6,8; 0
,,,tmVar:c|SUB|C|1042|T;HGVS:c.1042C>T;VariantGroup:0;CorrespondingGene:3766;RS#:137853074;CorrespondingSpecies:9606;CA#:254188,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),neonatal deafness (MESH:D003638); hearing loss (MESH:D034381),substitution,c.1042C>T,unknown,31243244,9; 5; 8,0; 0
,,,tmVar:c|SUB|G|416|A;HGVS:c.416G>A;VariantGroup:4;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),,substitution,c.416G>A,unknown,32447495,8; 3; 2,
,,,tmVar:c|SUB|G|823|A;HGVS:c.823G>A;VariantGroup:0;CorrespondingGene:2299;RS#:145129881;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),,substitution,c.823G>A,unknown,32447495,5; 4; 4,
,,,tmVar:c|SUB|G|1027|C;HGVS:c.1027G>C;VariantGroup:3;CorrespondingGene:5172;CorrespondingSpecies:9606,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),,substitution,c.1027G>C,unknown,32447495,8; 8; 8,
,,,tmVar:c|SUB|C|214|A;HGVS:c.214C>A;VariantGroup:2;CorrespondingGene:2299;RS#:749678694;CorrespondingSpecies:9606;CA#:3554981,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),,substitution,c.214C>A,unknown,32447495,8; 9; 6,
,,,tmVar:c|SUB|C|1054|A;HGVS:c.1054C>A;VariantGroup:1;CorrespondingGene:3766;RS#:888967595;CorrespondingSpecies:9606;CA#:31470087,SLC26A4 (5172); FOXI1 (2299); KCNJ10 (3766),,substitution,c.1054C>A,unknown,32447495,4; 4; 9,
,,,tmVar:c|SUB|C|1765|T;HGVS:c.1765C>T;VariantGroup:2;CorrespondingGene:6521;RS#:121912745;CorrespondingSpecies:9606;CA#:127388,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.1765C>T,unknown,34157794,8; 0; 0; 8; 8,9; 9; 0
,,,tmVar:p|SUB|R|589|C;HGVS:p.R589C;VariantGroup:2;CorrespondingGene:6521;RS#:121912745;CorrespondingSpecies:9606;CA#:127388,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.R589C,unknown,34157794,0; 0; 0; 0; 0,0; 0; 0
,,,tmVar:c|SUB|G|368|T;HGVS:c.368G>T;VariantGroup:1;CorrespondingGene:525;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); Primary distal renal tubular acidosis (dRTA) (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.368G>T,unknown,34157794,7; 0; 0; 7; 7,0; 9; 9; 0
,,,tmVar:p|SUB|G|123|V;HGVS:p.G123V;VariantGroup:1;CorrespondingGene:525;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.G123V,unknown,34157794,9; 0; 4; 6; 8,10; 10; 3
,,,tmVar:c|SUB|C|370|T;HGVS:c.370C>T;VariantGroup:0;CorrespondingGene:525;RS#:727505222(Expired);CorrespondingSpecies:9606;CA#:185431,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); Primary distal renal tubular acidosis (dRTA) (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.370C>T,unknown,34157794,9; 0; 0; 0; 8,0; 6; 6; 3
,,,tmVar:p|SUB|R|124|W;HGVS:p.R124W;VariantGroup:0;CorrespondingGene:525;RS#:727505222(Expired);CorrespondingSpecies:9606;CA#:185431,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.R124W,unknown,34157794,7; 0; 0; 4; 7,6; 6; 3
,,,tmVar:c|SUB|G|484|T;HGVS:c.484G>T;VariantGroup:6;CorrespondingGene:50617;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); Primary distal renal tubular acidosis (dRTA) (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.484G>T,unknown,34157794,7; 0; 0; 7; 7,0; 9; 9; 0
,,,tmVar:p|SUB|E|162|*;HGVS:p.E162*;VariantGroup:4;CorrespondingGene:50617;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.E162*,unknown,34157794,7; 0; 0; 7; 7,9; 9; 4
,,,tmVar:c|SUB|G|1102|A;HGVS:c.1102G>A;VariantGroup:1;CorrespondingGene:525;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); Primary distal renal tubular acidosis (dRTA) (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.1102G>A,unknown,34157794,8; 0; 0; 6; 8,0; 7; 7; 0
,,,tmVar:p|SUB|E|368|K;HGVS:p.E368K;VariantGroup:1;CorrespondingGene:525;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.E368K,unknown,34157794,9; 0; 0; 6; 7,8; 8; 0
,,,tmVar:c|SUB|C|322|T;HGVS:c.322C>T;VariantGroup:5;CorrespondingGene:50617;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.322C>T,unknown,34157794,8; 0; 0; 9; 9,10; 10; 0
,,,tmVar:p|SUB|Q|108|*;HGVS:p.Q108*;VariantGroup:7;CorrespondingGene:50617;CorrespondingSpecies:9606,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.Q108*,unknown,34157794,7; 0; 0; 7; 7,9; 9; 0
,,,tmVar:c|SUB|G|1572|A;HGVS:c.1572G>A;VariantGroup:3;CorrespondingGene:50617;RS#:773840097;CorrespondingSpecies:9606;CA#:4504731,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,c.1572G>A,unknown,34157794,8; 0; 0; 8; 8,6; 6; 3
,,,tmVar:p|SUB|P|524|P;HGVS:p.P524P;VariantGroup:3;CorrespondingGene:50617;RS#:773840097;CorrespondingSpecies:9606;CA#:4504731,ATP6V1B1 (525); FOXI1 (2299); WDR72 (256764); ATP6V0A4 (50617); SLC4A1 (6521),Primary distal renal tubular acidosis (MESH:D000141); dRTA (MESH:D000141); tubular disease (MESH:D000230),substitution,p.P524P,unknown,34157794,7; 0; 0; 7; 7,8; 8; 0
,,,tmVar:c|DUP|748|G|;HGVS:c.748dupG;VariantGroup:3;CorrespondingGene:2299;CorrespondingSpecies:9606,FOXI1 (2299),congenital deafness (MESH:D003638); hearing loss (MESH:D034381); enlarged vestibular aqueduct (OMIM:600791),duplication,c.748dupG,unknown,36184087,9,9; 7; 9
,,,"tmVar:p|FS|D|250|G,N|30;HGVS:p.D250G,NfsX30;VariantGroup:1;CorrespondingGene:2299;CorrespondingSpecies:9606",FOXI1 (2299),congenital deafness (MESH:D003638); hearing loss (MESH:D034381); enlarged vestibular aqueduct (OMIM:600791),unknown,"p.D250G,NfsX30",unknown,36184087,9,8; 0; 9
,,,tmVar:c|SUB|C|879|A;HGVS:c.879C>A;VariantGroup:2;CorrespondingGene:2299;CorrespondingSpecies:9606,FOXI1 (2299),congenital deafness (MESH:D003638); hereditary deafness ( ); hearing loss (MESH:D034381); enlarged vestibular aqueduct (OMIM:600791),substitution,c.879C>A,unknown,36184087,8,8; 5; 6; 8
,,,tmVar:p|SUB|S|293|R;HGVS:p.S293R;VariantGroup:0;CorrespondingGene:2299;RS#:778920857;CorrespondingSpecies:9606,FOXI1 (2299),congenital deafness (MESH:D003638); hearing loss (MESH:D034381); enlarged vestibular aqueduct (OMIM:600791),substitution,p.S293R,unknown,36184087,9,6; 5; 6
